34737695|t|Calycosin Alleviates Sepsis-Induced Acute Lung Injury via the Inhibition of Mitochondrial ROS-Mediated Inflammasome Activation.
34737695|a|Sepsis-induced acute lung injury (ALI) culminates in multiple organ failure via uncontrolled inflammatory responses and requires effective treatment. Herein, we aimed to investigate the effect of calycosin (CA), a natural isoflavonoid, on sepsis-induced ALI. CA attenuated lipopolysaccharide (LPS) and cecal ligation and puncture (CLP)-induced structural damage and inflammatory cell infiltration in lung tissues by histopathological analysis. CA significantly reduced lung wet/dry ratio, inflammatory cell infiltration in bronchoalveolar lavage fluid, and myeloperoxidase activity. Moreover, CA improved the survival of septic mice. CA also substantially inhibited interleukin (IL)-1beta and IL-18 levels and cleaved caspase 1 expression and activity in lung tissues. Additionally, CA markedly suppressed oxidative stress by increasing levels of superoxide dismutase and glutathione while decreasing malondialdehyde. In vitro assay showed that CA significantly inhibited LPS-induced IL-1beta and IL-18 levels and cleaved caspase 1 expression and activity in BMDMs. Moreover, CA blocked the interaction among NLRP3, ASC, and caspase 1 in LPS-treated cells. CA markedly reduced mitochondrial ROS levels. Significantly, compared with CA treatment, the combination of CA and MitoTEMPO (mitochondria-targeted antioxidant) did not further reduce the IL-1beta and IL-18 levels and cleaved caspase 1 expression and activity and decreased mitochondrial ROS levels. Collectively, the inhibition of mitochondrial ROS-mediated NLRP3 inflammasome activation contributes to the protective effects of CA, which may be considered a potential therapeutic agent for septic ALI.
34737695	0	9	Calycosin	Chemical	MESH:C121707
34737695	21	27	Sepsis	Disease	MESH:D018805
34737695	36	53	Acute Lung Injury	Disease	MESH:D055371
34737695	90	93	ROS	Chemical	-
34737695	128	134	Sepsis	Disease	MESH:D018805
34737695	143	160	acute lung injury	Disease	MESH:D055371
34737695	162	165	ALI	Disease	MESH:D055371
34737695	181	203	multiple organ failure	Disease	MESH:D009102
34737695	221	233	inflammatory	Disease	MESH:D007249
34737695	324	333	calycosin	Chemical	MESH:C121707
34737695	350	362	isoflavonoid	Chemical	-
34737695	367	373	sepsis	Disease	MESH:D018805
34737695	382	385	ALI	Disease	MESH:D055371
34737695	401	419	lipopolysaccharide	Chemical	MESH:D008070
34737695	421	424	LPS	Chemical	MESH:D008070
34737695	494	506	inflammatory	Disease	MESH:D007249
34737695	617	629	inflammatory	Disease	MESH:D007249
34737695	685	700	myeloperoxidase	Gene	17523
34737695	756	760	mice	Species	10090
34737695	794	816	interleukin (IL)-1beta	Gene	16176
34737695	821	826	IL-18	Gene	16173
34737695	846	855	caspase 1	Gene	12362
34737695	1000	1011	glutathione	Chemical	MESH:D005978
34737695	1029	1044	malondialdehyde	Chemical	MESH:D008315
34737695	1100	1103	LPS	Chemical	MESH:D008070
34737695	1112	1120	IL-1beta	Gene	16176
34737695	1125	1130	IL-18	Gene	16173
34737695	1150	1159	caspase 1	Gene	12362
34737695	1237	1242	NLRP3	Gene	216799
34737695	1244	1247	ASC	Gene	20905
34737695	1253	1262	caspase 1	Gene	12362
34737695	1266	1269	LPS	Chemical	MESH:D008070
34737695	1319	1322	ROS	Chemical	-
34737695	1400	1409	MitoTEMPO	Chemical	MESH:C555916
34737695	1473	1481	IL-1beta	Gene	16176
34737695	1486	1491	IL-18	Gene	16173
34737695	1511	1520	caspase 1	Gene	12362
34737695	1573	1576	ROS	Chemical	-
34737695	1631	1634	ROS	Chemical	-
34737695	1644	1649	NLRP3	Gene	216799
34737695	1784	1787	ALI	Disease	MESH:D055371
34737695	Positive_Correlation	MESH:D008070	16176
34737695	Positive_Correlation	MESH:D008070	16173
34737695	Association	12362	216799
34737695	Negative_Correlation	MESH:C121707	MESH:D055371
34737695	Association	12362	20905
34737695	Negative_Correlation	MESH:C121707	MESH:D018805
34737695	Association	MESH:D055371	216799

